治疗严重失控喘的生物药物的真实安全性:来自西班牙药监数据库的描述性分析
Carlos Boada-Fernández-Del-Campo1,2,3, Marcelino García-Sánchez-Colomer1,2, Eduardo Fernández-Quintana1,2
1Autonomous Pharmacovigilance Center of the Canary Islands (CAFV), Hospital Universitario de Canarias, 38320 Santa Cruz de Tenerife, Spain.
这项研究分析了西班牙严重喘生物学药物的不良药物反应 (ADR). 它发现报告的副作用和药物信息表之间的差异,突出了改善药物监督的必要性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 药品安全 药品安全
背景情况:
- 对用于严重耐火性喘的生物制剂的不良药物反应 (ADR) 的分析.
- 专注于奥马利祖马布,梅波利祖马布,雷斯利祖马布,本拉利祖马布,杜比卢马布和特泽佩卢马布.
- 利用了西班牙药监系统 (FEDRA) 的数据.
研究的目的:
- 识别药物的技术说明书 (产品特性摘要,SmPC) 中未列出的ADR.
- 检测与这些生物药物相关的潜在未知的风险.
- 加强严重喘治疗的药物监测.
主要方法:
- 从市场推出到2024年1月,对ADR数据的回顾性分析.
- 数据来源于直接提交,行业通讯和文献评论.
- 对所有报告的不良反应进行公正的评估,以便进行全面的审查.
主要成果:
- 营销后监测对于生物喘治疗中的患者安全至关重要.
- 医疗保健专业人员全面报告ADR对于强大的药物监督至关重要.
- 在报告的有害反应和SmPC信息之间发现了差距,表明了需要改善安全监测的领域.
结论:
- 调查结果支持针对严重失控喘管理的知情临床实践和监管政策.
- 强调需要更新药物安全信息和监管监督.
- 旨在通过加强药物监测来推进患者护理和安全.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Dose-Response Relationship: Selectivity and Specificity
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
